Temozolomide resistance in glioblastoma multiforme-Reference-Cited by-同舟云学术

Temozolomide resistance in glioblastoma multiforme

Published:2016-09 Issue:3 Volume:3 Page:198-210
ISSN:2352-3042
Container-title:Genes & Diseases
language:en
Short-container-title:Genes & Diseases

Author:

Lee Sang Y.

Funder

Gittlen Foundation

Publisher

Elsevier BV

Subject

Cell Biology,Genetics (clinical),Molecular Biology,Biochemistry

Reference54 articles.

1. The medicinal chemistry of imidazotetrazine prodrugs;Moody;Pharmaceuticals (Basel),2014

2. Pharmacokinetics of 3-methyl-(triazen-1-yl)imidazole-4-carboximide following administration of temozolomide to patients with advanced cancer;Reid;Clin Cancer Res,1997

3. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma;Middleton;J Clin Oncol,2000

4. Temozolomide for the treatment of metastatic melanoma: a systematic review;Quirt;Oncologist,2007

5. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group;Yung;J Clin Oncol,1999

Cited by 797 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabidiol and fluorinated derivative anti-cancer properties against glioblastoma multiforme cell lines, and synergy with imidazotetrazine agents;BJC Reports;2024-09-09

2. Molecular Profile as an Outcome Predictor in Glioblastoma along with MRI Features and Surgical Resection: A Scoping Review;International Journal of Molecular Sciences;2024-09-08

3. Eslicarbazepine induces apoptosis and cell cycle arrest in C6 glioma cells in vitro and suppresses tumor growth in an intracranial rat model;BMC Cancer;2024-09-04

4. Two decades of progress in glioma methylation research: the rise of temozolomide resistance and immunotherapy insights;Frontiers in Neuroscience;2024-09-02

5. Enhanced treatment of breast cancer brain metastases with oncolytic virus expressing anti-CD47 antibody and temozolomide;Molecular Therapy: Oncology;2024-09